Global Split Influenza Vaccine Market Growth 2026-2032
The global Split Influenza Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Influenza virus split vaccine is made by inoculating chicken embryos with influenza virus strains recommended by the World Health Organization (WHO) and approved by the national drug administration department, cultured, harvested virus liquid, virus inactivated, purified, and cracked. For the prevention of influenza caused by this type of virus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Split Influenza Vaccine Industry Forecast? looks at past sales and reviews total world Split Influenza Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Split Influenza Vaccine sales for 2026 through 2032. With Split Influenza Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Split Influenza Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Split Influenza Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Split Influenza Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Split Influenza Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Split Influenza Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Split Influenza Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Split Influenza Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Influenza virus split vaccine is made by inoculating chicken embryos with influenza virus strains recommended by the World Health Organization (WHO) and approved by the national drug administration department, cultured, harvested virus liquid, virus inactivated, purified, and cracked. For the prevention of influenza caused by this type of virus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Split Influenza Vaccine Industry Forecast? looks at past sales and reviews total world Split Influenza Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Split Influenza Vaccine sales for 2026 through 2032. With Split Influenza Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Split Influenza Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Split Influenza Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Split Influenza Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Split Influenza Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Split Influenza Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Split Influenza Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Split Influenza Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Aldult
- Child
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi Pasteur
- CSL Seqirus
- GSK
- Seqirus, Inc.
- straZeneca
- Dalian Yali Peak
- What is the 10-year outlook for the global Split Influenza Vaccine market?
- What factors are driving Split Influenza Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Split Influenza Vaccine market opportunities vary by end market size?
- How does Split Influenza Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Split Influenza Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Split Influenza Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Split Influenza Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Split Influenza Vaccine Segment by Type
2.2.1 Aldult
2.2.2 Child
2.2.3 Split Influenza Vaccine Sales by Type
2.2.3.1 Global Split Influenza Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Split Influenza Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Split Influenza Vaccine Sale Price by Type (2021-2026)
2.3 Split Influenza Vaccine Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Split Influenza Vaccine Sales by Application
2.3.3.1 Global Split Influenza Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Split Influenza Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Split Influenza Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Split Influenza Vaccine Breakdown Data by Company
3.1.1 Global Split Influenza Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Split Influenza Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Split Influenza Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Split Influenza Vaccine Revenue by Company (2021-2026)
3.2.2 Global Split Influenza Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Split Influenza Vaccine Sale Price by Company
3.4 Key Manufacturers Split Influenza Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Split Influenza Vaccine Product Location Distribution
3.4.2 Players Split Influenza Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SPLIT INFLUENZA VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Split Influenza Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Split Influenza Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Split Influenza Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Split Influenza Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Split Influenza Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Split Influenza Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Split Influenza Vaccine Sales Growth
4.4 APAC Split Influenza Vaccine Sales Growth
4.5 Europe Split Influenza Vaccine Sales Growth
4.6 Middle East & Africa Split Influenza Vaccine Sales Growth
5 AMERICAS
5.1 Americas Split Influenza Vaccine Sales by Country
5.1.1 Americas Split Influenza Vaccine Sales by Country (2021-2026)
5.1.2 Americas Split Influenza Vaccine Revenue by Country (2021-2026)
5.2 Americas Split Influenza Vaccine Sales by Type (2021-2026)
5.3 Americas Split Influenza Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Split Influenza Vaccine Sales by Region
6.1.1 APAC Split Influenza Vaccine Sales by Region (2021-2026)
6.1.2 APAC Split Influenza Vaccine Revenue by Region (2021-2026)
6.2 APAC Split Influenza Vaccine Sales by Type (2021-2026)
6.3 APAC Split Influenza Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Split Influenza Vaccine by Country
7.1.1 Europe Split Influenza Vaccine Sales by Country (2021-2026)
7.1.2 Europe Split Influenza Vaccine Revenue by Country (2021-2026)
7.2 Europe Split Influenza Vaccine Sales by Type (2021-2026)
7.3 Europe Split Influenza Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Split Influenza Vaccine by Country
8.1.1 Middle East & Africa Split Influenza Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Split Influenza Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Split Influenza Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Split Influenza Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Split Influenza Vaccine
10.3 Manufacturing Process Analysis of Split Influenza Vaccine
10.4 Industry Chain Structure of Split Influenza Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Split Influenza Vaccine Distributors
11.3 Split Influenza Vaccine Customer
12 WORLD FORECAST REVIEW FOR SPLIT INFLUENZA VACCINE BY GEOGRAPHIC REGION
12.1 Global Split Influenza Vaccine Market Size Forecast by Region
12.1.1 Global Split Influenza Vaccine Forecast by Region (2027-2032)
12.1.2 Global Split Influenza Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Split Influenza Vaccine Forecast by Type (2027-2032)
12.7 Global Split Influenza Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Split Influenza Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Pasteur Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 CSL Seqirus
13.2.1 CSL Seqirus Company Information
13.2.2 CSL Seqirus Split Influenza Vaccine Product Portfolios and Specifications
13.2.3 CSL Seqirus Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CSL Seqirus Main Business Overview
13.2.5 CSL Seqirus Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Split Influenza Vaccine Product Portfolios and Specifications
13.3.3 GSK Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Seqirus, Inc.
13.4.1 Seqirus, Inc. Company Information
13.4.2 Seqirus, Inc. Split Influenza Vaccine Product Portfolios and Specifications
13.4.3 Seqirus, Inc. Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Seqirus, Inc. Main Business Overview
13.4.5 Seqirus, Inc. Latest Developments
13.5 straZeneca
13.5.1 straZeneca Company Information
13.5.2 straZeneca Split Influenza Vaccine Product Portfolios and Specifications
13.5.3 straZeneca Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 straZeneca Main Business Overview
13.5.5 straZeneca Latest Developments
13.6 Dalian Yali Peak
13.6.1 Dalian Yali Peak Company Information
13.6.2 Dalian Yali Peak Split Influenza Vaccine Product Portfolios and Specifications
13.6.3 Dalian Yali Peak Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Dalian Yali Peak Main Business Overview
13.6.5 Dalian Yali Peak Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Split Influenza Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Split Influenza Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Split Influenza Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Split Influenza Vaccine Segment by Type
2.2.1 Aldult
2.2.2 Child
2.2.3 Split Influenza Vaccine Sales by Type
2.2.3.1 Global Split Influenza Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Split Influenza Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Split Influenza Vaccine Sale Price by Type (2021-2026)
2.3 Split Influenza Vaccine Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Split Influenza Vaccine Sales by Application
2.3.3.1 Global Split Influenza Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Split Influenza Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Split Influenza Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Split Influenza Vaccine Breakdown Data by Company
3.1.1 Global Split Influenza Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Split Influenza Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Split Influenza Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Split Influenza Vaccine Revenue by Company (2021-2026)
3.2.2 Global Split Influenza Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Split Influenza Vaccine Sale Price by Company
3.4 Key Manufacturers Split Influenza Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Split Influenza Vaccine Product Location Distribution
3.4.2 Players Split Influenza Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SPLIT INFLUENZA VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Split Influenza Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Split Influenza Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Split Influenza Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Split Influenza Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Split Influenza Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Split Influenza Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Split Influenza Vaccine Sales Growth
4.4 APAC Split Influenza Vaccine Sales Growth
4.5 Europe Split Influenza Vaccine Sales Growth
4.6 Middle East & Africa Split Influenza Vaccine Sales Growth
5 AMERICAS
5.1 Americas Split Influenza Vaccine Sales by Country
5.1.1 Americas Split Influenza Vaccine Sales by Country (2021-2026)
5.1.2 Americas Split Influenza Vaccine Revenue by Country (2021-2026)
5.2 Americas Split Influenza Vaccine Sales by Type (2021-2026)
5.3 Americas Split Influenza Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Split Influenza Vaccine Sales by Region
6.1.1 APAC Split Influenza Vaccine Sales by Region (2021-2026)
6.1.2 APAC Split Influenza Vaccine Revenue by Region (2021-2026)
6.2 APAC Split Influenza Vaccine Sales by Type (2021-2026)
6.3 APAC Split Influenza Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Split Influenza Vaccine by Country
7.1.1 Europe Split Influenza Vaccine Sales by Country (2021-2026)
7.1.2 Europe Split Influenza Vaccine Revenue by Country (2021-2026)
7.2 Europe Split Influenza Vaccine Sales by Type (2021-2026)
7.3 Europe Split Influenza Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Split Influenza Vaccine by Country
8.1.1 Middle East & Africa Split Influenza Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Split Influenza Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Split Influenza Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Split Influenza Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Split Influenza Vaccine
10.3 Manufacturing Process Analysis of Split Influenza Vaccine
10.4 Industry Chain Structure of Split Influenza Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Split Influenza Vaccine Distributors
11.3 Split Influenza Vaccine Customer
12 WORLD FORECAST REVIEW FOR SPLIT INFLUENZA VACCINE BY GEOGRAPHIC REGION
12.1 Global Split Influenza Vaccine Market Size Forecast by Region
12.1.1 Global Split Influenza Vaccine Forecast by Region (2027-2032)
12.1.2 Global Split Influenza Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Split Influenza Vaccine Forecast by Type (2027-2032)
12.7 Global Split Influenza Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Split Influenza Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Pasteur Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 CSL Seqirus
13.2.1 CSL Seqirus Company Information
13.2.2 CSL Seqirus Split Influenza Vaccine Product Portfolios and Specifications
13.2.3 CSL Seqirus Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CSL Seqirus Main Business Overview
13.2.5 CSL Seqirus Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Split Influenza Vaccine Product Portfolios and Specifications
13.3.3 GSK Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Seqirus, Inc.
13.4.1 Seqirus, Inc. Company Information
13.4.2 Seqirus, Inc. Split Influenza Vaccine Product Portfolios and Specifications
13.4.3 Seqirus, Inc. Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Seqirus, Inc. Main Business Overview
13.4.5 Seqirus, Inc. Latest Developments
13.5 straZeneca
13.5.1 straZeneca Company Information
13.5.2 straZeneca Split Influenza Vaccine Product Portfolios and Specifications
13.5.3 straZeneca Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 straZeneca Main Business Overview
13.5.5 straZeneca Latest Developments
13.6 Dalian Yali Peak
13.6.1 Dalian Yali Peak Company Information
13.6.2 Dalian Yali Peak Split Influenza Vaccine Product Portfolios and Specifications
13.6.3 Dalian Yali Peak Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Dalian Yali Peak Main Business Overview
13.6.5 Dalian Yali Peak Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Split Influenza Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Split Influenza Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Aldult
Table 4. Major Players of Child
Table 5. Global Split Influenza Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Split Influenza Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Split Influenza Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Split Influenza Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Split Influenza Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Split Influenza Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Split Influenza Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Split Influenza Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Split Influenza Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Split Influenza Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Split Influenza Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Split Influenza Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Split Influenza Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Split Influenza Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Split Influenza Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Split Influenza Vaccine Producing Area Distribution and Sales Area
Table 21. Players Split Influenza Vaccine Products Offered
Table 22. Split Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Split Influenza Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Split Influenza Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Split Influenza Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Split Influenza Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Split Influenza Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Split Influenza Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Split Influenza Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Split Influenza Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Split Influenza Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Split Influenza Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Split Influenza Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Split Influenza Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Split Influenza Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Split Influenza Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Split Influenza Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Split Influenza Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Split Influenza Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Split Influenza Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Split Influenza Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Split Influenza Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Split Influenza Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Split Influenza Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Split Influenza Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Split Influenza Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Split Influenza Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Split Influenza Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Split Influenza Vaccine
Table 52. Key Market Challenges & Risks of Split Influenza Vaccine
Table 53. Key Industry Trends of Split Influenza Vaccine
Table 54. Split Influenza Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Split Influenza Vaccine Distributors List
Table 57. Split Influenza Vaccine Customer List
Table 58. Global Split Influenza Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Split Influenza Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Split Influenza Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Split Influenza Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Split Influenza Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Split Influenza Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Split Influenza Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Split Influenza Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Split Influenza Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Split Influenza Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Split Influenza Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Split Influenza Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Split Influenza Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Split Influenza Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Sanofi Pasteur Basic Information, Split Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Pasteur Split Influenza Vaccine Product Portfolios and Specifications
Table 74. Sanofi Pasteur Split Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Sanofi Pasteur Main Business
Table 76. Sanofi Pasteur Latest Developments
Table 77. CSL Seqirus Basic Information, Split Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. CSL Seqirus Split Influenza Vaccine Product Portfolios and Specifications
Table 79. CSL Seqirus Split Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. CSL Seqirus Main Business
Table 81. CSL Seqirus Latest Developments
Table 82. GSK Basic Information, Split Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. GSK Split Influenza Vaccine Product Portfolios and Specifications
Table 84. GSK Split Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. GSK Main Business
Table 86. GSK Latest Developments
Table 87. Seqirus, Inc. Basic Information, Split Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Seqirus, Inc. Split Influenza Vaccine Product Portfolios and Specifications
Table 89. Seqirus, Inc. Split Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Seqirus, Inc. Main Business
Table 91. Seqirus, Inc. Latest Developments
Table 92. straZeneca Basic Information, Split Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. straZeneca Split Influenza Vaccine Product Portfolios and Specifications
Table 94. straZeneca Split Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. straZeneca Main Business
Table 96. straZeneca Latest Developments
Table 97. Dalian Yali Peak Basic Information, Split Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Dalian Yali Peak Split Influenza Vaccine Product Portfolios and Specifications
Table 99. Dalian Yali Peak Split Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Dalian Yali Peak Main Business
Table 101. Dalian Yali Peak Latest Developments
Table 1. Split Influenza Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Split Influenza Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Aldult
Table 4. Major Players of Child
Table 5. Global Split Influenza Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Split Influenza Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Split Influenza Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Split Influenza Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Split Influenza Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Split Influenza Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Split Influenza Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Split Influenza Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Split Influenza Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Split Influenza Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Split Influenza Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Split Influenza Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Split Influenza Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Split Influenza Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Split Influenza Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Split Influenza Vaccine Producing Area Distribution and Sales Area
Table 21. Players Split Influenza Vaccine Products Offered
Table 22. Split Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Split Influenza Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Split Influenza Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Split Influenza Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Split Influenza Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Split Influenza Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Split Influenza Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Split Influenza Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Split Influenza Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Split Influenza Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Split Influenza Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Split Influenza Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Split Influenza Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Split Influenza Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Split Influenza Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Split Influenza Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Split Influenza Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Split Influenza Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Split Influenza Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Split Influenza Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Split Influenza Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Split Influenza Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Split Influenza Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Split Influenza Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Split Influenza Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Split Influenza Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Split Influenza Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Split Influenza Vaccine
Table 52. Key Market Challenges & Risks of Split Influenza Vaccine
Table 53. Key Industry Trends of Split Influenza Vaccine
Table 54. Split Influenza Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Split Influenza Vaccine Distributors List
Table 57. Split Influenza Vaccine Customer List
Table 58. Global Split Influenza Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Split Influenza Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Split Influenza Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Split Influenza Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Split Influenza Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Split Influenza Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Split Influenza Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Split Influenza Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Split Influenza Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Split Influenza Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Split Influenza Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Split Influenza Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Split Influenza Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Split Influenza Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Sanofi Pasteur Basic Information, Split Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Pasteur Split Influenza Vaccine Product Portfolios and Specifications
Table 74. Sanofi Pasteur Split Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Sanofi Pasteur Main Business
Table 76. Sanofi Pasteur Latest Developments
Table 77. CSL Seqirus Basic Information, Split Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. CSL Seqirus Split Influenza Vaccine Product Portfolios and Specifications
Table 79. CSL Seqirus Split Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. CSL Seqirus Main Business
Table 81. CSL Seqirus Latest Developments
Table 82. GSK Basic Information, Split Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. GSK Split Influenza Vaccine Product Portfolios and Specifications
Table 84. GSK Split Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. GSK Main Business
Table 86. GSK Latest Developments
Table 87. Seqirus, Inc. Basic Information, Split Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Seqirus, Inc. Split Influenza Vaccine Product Portfolios and Specifications
Table 89. Seqirus, Inc. Split Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Seqirus, Inc. Main Business
Table 91. Seqirus, Inc. Latest Developments
Table 92. straZeneca Basic Information, Split Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. straZeneca Split Influenza Vaccine Product Portfolios and Specifications
Table 94. straZeneca Split Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. straZeneca Main Business
Table 96. straZeneca Latest Developments
Table 97. Dalian Yali Peak Basic Information, Split Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Dalian Yali Peak Split Influenza Vaccine Product Portfolios and Specifications
Table 99. Dalian Yali Peak Split Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Dalian Yali Peak Main Business
Table 101. Dalian Yali Peak Latest Developments
LIST OF FIGURES
Figure 1. Picture of Split Influenza Vaccine
Figure 2. Split Influenza Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Split Influenza Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Split Influenza Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Split Influenza Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Split Influenza Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Split Influenza Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Aldult
Figure 12. Product Picture of Child
Figure 13. Global Split Influenza Vaccine Sales Market Share by Type in 2026
Figure 14. Global Split Influenza Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Split Influenza Vaccine Consumed in Hospital
Figure 16. Global Split Influenza Vaccine Market: Hospital (2021-2026) & (K Units)
Figure 17. Split Influenza Vaccine Consumed in Clinic
Figure 18. Global Split Influenza Vaccine Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Split Influenza Vaccine Sale Market Share by Application (2025)
Figure 20. Global Split Influenza Vaccine Revenue Market Share by Application in 2026
Figure 21. Split Influenza Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Split Influenza Vaccine Sales Market Share by Company in 2026
Figure 23. Split Influenza Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Split Influenza Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Split Influenza Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Split Influenza Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Split Influenza Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Split Influenza Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Split Influenza Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Split Influenza Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Split Influenza Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Split Influenza Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Split Influenza Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Split Influenza Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Split Influenza Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Split Influenza Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Split Influenza Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Split Influenza Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Split Influenza Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Split Influenza Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Split Influenza Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Split Influenza Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Split Influenza Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Split Influenza Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Split Influenza Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Split Influenza Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Split Influenza Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Split Influenza Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Split Influenza Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Split Influenza Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Split Influenza Vaccine
Figure 73. Industry Chain Structure of Split Influenza Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Split Influenza Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Split Influenza Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Split Influenza Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Split Influenza Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Split Influenza Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Split Influenza Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Split Influenza Vaccine
Figure 2. Split Influenza Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Split Influenza Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Split Influenza Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Split Influenza Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Split Influenza Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Split Influenza Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Aldult
Figure 12. Product Picture of Child
Figure 13. Global Split Influenza Vaccine Sales Market Share by Type in 2026
Figure 14. Global Split Influenza Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Split Influenza Vaccine Consumed in Hospital
Figure 16. Global Split Influenza Vaccine Market: Hospital (2021-2026) & (K Units)
Figure 17. Split Influenza Vaccine Consumed in Clinic
Figure 18. Global Split Influenza Vaccine Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Split Influenza Vaccine Sale Market Share by Application (2025)
Figure 20. Global Split Influenza Vaccine Revenue Market Share by Application in 2026
Figure 21. Split Influenza Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Split Influenza Vaccine Sales Market Share by Company in 2026
Figure 23. Split Influenza Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Split Influenza Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Split Influenza Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Split Influenza Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Split Influenza Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Split Influenza Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Split Influenza Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Split Influenza Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Split Influenza Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Split Influenza Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Split Influenza Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Split Influenza Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Split Influenza Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Split Influenza Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Split Influenza Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Split Influenza Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Split Influenza Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Split Influenza Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Split Influenza Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Split Influenza Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Split Influenza Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Split Influenza Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Split Influenza Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Split Influenza Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Split Influenza Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Split Influenza Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Split Influenza Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Split Influenza Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Split Influenza Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Split Influenza Vaccine
Figure 73. Industry Chain Structure of Split Influenza Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Split Influenza Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Split Influenza Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Split Influenza Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Split Influenza Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Split Influenza Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Split Influenza Vaccine Revenue Market Share Forecast by Application (2027-2032)
